Dimensional Fund Advisors LP Buys 305,837 Shares of Revvity Inc. $RVTY

Dimensional Fund Advisors LP raised its stake in Revvity Inc. (NYSE:RVTY) by 11.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,917,953 shares of the company’s stock after purchasing an additional 305,837 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Revvity were worth $255,623,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of RVTY. Price T Rowe Associates Inc. MD boosted its position in shares of Revvity by 5.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after buying an additional 434,570 shares during the last quarter. Janus Henderson Group PLC lifted its stake in Revvity by 7.0% during the 4th quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock valued at $789,595,000 after acquiring an additional 533,912 shares in the last quarter. Morgan Stanley lifted its stake in Revvity by 29.6% during the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after acquiring an additional 650,083 shares in the last quarter. Invesco Ltd. boosted its holdings in Revvity by 15.7% during the 3rd quarter. Invesco Ltd. now owns 2,553,515 shares of the company’s stock worth $223,816,000 after acquiring an additional 346,313 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in Revvity by 29.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,259,286 shares of the company’s stock worth $198,636,000 after acquiring an additional 507,674 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Up 0.2%

Shares of Revvity stock opened at $110.78 on Thursday. The firm has a market cap of $12.36 billion, a PE ratio of 53.01, a P/E/G ratio of 2.17 and a beta of 1.09. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The stock has a fifty day moving average price of $104.24 and a 200-day moving average price of $99.43.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts anticipate that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is presently 13.40%.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Sanford C. Bernstein began coverage on shares of Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price for the company. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. JPMorgan Chase & Co. cut their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Finally, Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Four equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Revvity currently has an average rating of “Hold” and a consensus price target of $108.92.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.